Evidence map›Paper›PMID 24772169›Full record

ReviewCurrent gerontology and geriatrics research2014

Senescent remodeling of the innate and adaptive immune system in the elderly men with prostate cancer.

Gianluigi Taverna, Mauro Seveso, Guido Giusti, Rodolfo Hurle, Pierpaolo Graziotti, Sanja Stifter, Maurizio Chiriva-Internati, Fabio Grizzi

Open access · hybridAbstract readReview
In one paragraph

Review in Current gerontology and geriatrics research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Age and Periodontal Health - Immunological View.Current oral health reports · 2018
    Article
  11. Article
  12. Article
  13. Article
  14. Inflammation and prostate cancer: friends or foe?Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2015
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Gianluigi TavernaHumanitas Clinical and Research Center, Via Manzoni 56, Rozzano, Milan 20089, Italy.
Mauro SevesoHumanitas Clinical and Research Center, Via Manzoni 56, Rozzano, Milan 20089, Italy.
Guido GiustiHumanitas Clinical and Research Center, Via Manzoni 56, Rozzano, Milan 20089, Italy.
Rodolfo HurleHumanitas Clinical and Research Center, Via Manzoni 56, Rozzano, Milan 20089, Italy.
Pierpaolo GraziottiHumanitas Clinical and Research Center, Via Manzoni 56, Rozzano, Milan 20089, Italy.
Sanja StifterDepartment of Pathology, School of Medicine, University of Rijeka, 51000 Rijeka, Croatia.
Maurizio Chiriva-InternatiDivision of Oncology and Hematology, Texas Tech University Health Sciences Center, Lubbock, TX 79409, USA.
Fabio GrizziHumanitas Clinical and Research Center, Via Manzoni 56, Rozzano, Milan 20089, Italy.
Humanitas University · ITTexas Tech University · USUniversity of Rijeka · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite years of intensive investigation that has been made in understanding prostate cancer, it remains a major cause of death in men worldwide. Prostate cancer emerges from multiple alterations that induce changes in expression patterns of genes and proteins that function in networks controlling critical cellular events. Based on the exponential aging of the population and the increasing life expectancy in industrialized Western countries, prostate cancer in the elderly men is becoming a disease of increasing significance. Aging is a progressive degenerative process strictly integrated with inflammation. Several theories have been proposed that attempt to define the role of chronic inflammation in aging including redox stress, mitochondrial damage, immunosenescence, and epigenetic modifications. Here, we review the innate and adaptive immune systems and their senescent remodeling in elderly men with prostate cancer.

Identifiers

PMID24772169
PMCPMC3977481
OpenAlexW2017235228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.